Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination nutraceutical supplement containing silymarin (the active extract from Silybum marianum, also known as milk thistle) and yeast β-glucan. The combination is designed to modulate inflammatory responses, improve metabolic homeostasis, and support liver health. Silymarin acts primarily as an antioxidant and anti-inflammatory agent, while yeast β-glucan has immunomodulatory effects by stimulating immune cells such as macrophages and dendritic cells. Together, these components may synergistically improve insulin sensitivity, reduce oxidative stress, and ameliorate obesity-related metabolic disturbances[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on silymarin + yeast β-glucan.